开发瘤透淋巴细胞治疗的创新策略,用于瘤治疗
Zhongjie Yu1, Jianhua Shi2, Yuan Fang3
1R&D, Qingdao Sino‑cell Biomedicine Co., Ltd., Qingdao, Shandong 266000, P.R. China.
Oncology reports
|April 26, 2024
概括
瘤透淋巴细胞 (TILs) 的采用转移对癌症免疫疗法有希望,但仅在某些患者中有效. 本综述探讨了增强TIL治疗以改善抗瘤反应和患者的治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 癌症仍然是全球主要的死亡原因,需要先进的治疗策略.
- 瘤透淋巴细胞 (TILs) 的采用转移是恶性瘤的有希望的免疫疗法.
- 目前的TIL治疗疗效仅限于一小部分癌症患者,突出显示需要改进.
研究的目的:
- 系统地审查基于TIL的治疗的发展史.
- 为增强TILs多维抗瘤能力提供一个独特的视角.
- 为提高TIL治疗的疗效和加快基于TIL治疗的发展做出贡献.
主要方法:
- 基于TIL治疗的发展史的系统审查和分析.
- 探索新策略来增强TIL的抗瘤功能.
- 讨论增强多维抗瘤能力的见解.
主要成果:
- 通过众多试验建立了基于TIL的治疗的临床安全性和有效性.
- 鉴定了TIL输液在诱导患者子组中抗瘤反应的疗效的局限性.
- 提出了增强TIL多维抗瘤能力的新视角.
结论:
- 基于TIL的治疗是一种临床验证的癌症免疫疗法.
- 加强TIL治疗对于扩大其临床适用性和有效性至关重要.
- 对新策略的进一步研究可以显著改善TIL治疗结果.
相关概念视频
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


